About this trial
evaluate the degree of association, and the predictive accuracy of the REPS (as a predictive tool) compared with the TOFr as a quantitative assessment tool for (rNMB) in surgical patients in the early postoperative phase. The TOFr will be measured at 0, 15, 30, 45, and 60 min after extubation.
Eligibility criteria
Qualifiers
Age group 18-65 years old
Both genders
Patients with American Society of Anesthesiologist physical status classification of 1 or 2.
Disqualifiers
Patients who are less than 18 years old or more than 65 years old.
Patients with planned scheduled recovery in the intensive care unit or if more than 10 minutes had elapsed since tracheal extubation until NMB monitoring at the PACU.
Patients on medications that interfere with muscle activity.
Known allergy to neuromuscular blocking agents.
Trial design
Treatments tested in this trial
- residual neuromuscular block risk prediction score